Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunction

J Androl. 2003 Nov-Dec;24(6 Suppl):S38-41. doi: 10.1002/j.1939-4640.2003.tb02744.x.
No abstract available

Publication types

  • Review

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / enzymology
  • Humans
  • Male
  • Phosphodiesterase Inhibitors / pharmacology*
  • Phosphodiesterase Inhibitors / therapeutic use
  • Phosphoric Diester Hydrolases / drug effects*

Substances

  • Phosphodiesterase Inhibitors
  • Phosphoric Diester Hydrolases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • PDE5A protein, human